Innovation Pharmaceuticals Inc 's

• CTIX's Stock Performance relative to its Competitors

Spyre Therapeutics Inc Share Performance +427.65% One Year

Spyre Therapeutics Inc Profile Spyre Therapeutics develops long-acting antibody therapies targeting inflammatory bowel and rheumatic diseases. More about Spyre Therapeutics Inc 's Market Share

Cellectar Biosciences Inc Share Performance -48.13% This Year

Cellectar Biosciences Inc Profile Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment. More about Cellectar Biosciences Inc 's Market Share

Cns Pharmaceuticals Inc Share Performance -6.96% This Year

Cns Pharmaceuticals Inc Profile CNS Pharmaceuticals Inc's business model focuses on developing innovative solutions and treatments for central nervous system diseases. More about Cns Pharmaceuticals Inc 's Market Share

Cocrystal Pharma Inc Share Performance -6.40% One Year

Cocrystal Pharma Inc Profile Cocrystal Pharma Inc.'s business model focuses on the development of antiviral therapeutics to address unmet medical needs. More about Cocrystal Pharma Inc 's Market Share

Cumberland Pharmaceuticals Inc Share Performance +91.21% This Year

Cumberland Pharmaceuticals Inc Profile Cumberland Pharmaceuticals Inc operates as a specialty pharmaceutical company, primarily focusing on acquiring, developing, and commercializing prescription products for acute care hospitals and selected niche markets. They aim to provide innovative pharmaceuticals that address unmet medical needs, primarily in the areas of infectious diseases, gastroenterology, and pain management. Their business model revolves around strategic acquisitions, partnerships, and licensing agreements to expand their product portfolio and deliver high-quality medications to healthcare providers and patients. More about Cumberland Pharmaceuticals Inc 's Market Share

Sources: Innovation Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 7:43 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Innovation Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.